Skip to main content

ARS Pharmaceuticals, Inc.

SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001671858

No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.0M in total; Third Point is the only superinvestor holding it.

Q4 2025 vs. Q3 2025

How the institutions holding ARS Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of SPRY: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders1882191+5
Shares83.6M24.6K90.2M+6.55M (+7.8%)
Value$840.4M$238.9K$1.05B+$209.9M (+25.0%)

2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (38)

Institutions that held ARS Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to SPRY in Q4 2025
InstitutionSharesValue% of portfolio
Millennium Management LLC3,168,406$36.9M0.03%
Tyro Capital Management LLC1,994,852$23.2M7.23%
Pavaki Capital Management LLC1,172,000$13.7M9.53%
FIL Ltd810,073$9.44M0.01%
Bank of Montreal643,407$7.50M0.00%
General American Investors Co Inc559,959$6.52M0.41%
Third Point LLCSuperinvestorThird Point556,237$6.48M0.09%
American Century Companies Inc455,766$5.31M0.00%
Investment Management Associates Inc311,503$3.63M1.01%
Creek Drive Management Group LLC295,863$3.45M2.54%
Royce & Associates LP207,051$2.41M0.02%
Boothbay Fund Management, LLC201,474$2.35M0.06%
HRT Financial LP68,645$799.0K0.00%
Los Angeles Capital Management LLC65,746$566.7K0.00%
Fox Run Management, L.L.C.38,587$449.5K0.07%
Canada Pension Plan Investment Board29,600$344.8K0.00%
Nano Cap New Millennium Growth Fund L P25,000$291.3K0.25%
Wealthspire Advisors, LLC23,650$275.5K0.00%
VARCOV Co.22,300$259.8K0.10%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management21,614$251.8K0.00%
Cetera Investment Advisers15,340$178.7K0.00%
Lazard Asset Management LLC14,347$167.1K0.00%
Sherbrooke Park Advisers LLC13,139$153.1K0.40%
Tannin Capital LLC13,066$152.2K0.14%
Blair William & Co11,600$135.1K0.00%
Cygnus Capital Advisors, LLC10,556$123.0K0.09%
Wealth Architects, LLC10,000$116.5K0.01%
Osterweis Capital Management Inc5,610$65.4K0.00%
Torren Management, LLC2,762$32.2K0.02%
Eastern Bank750$8.74K0.00%
Hilton Head Capital Partners, LLC365$4.25K0.00%
Quarry LP250$2.91K0.00%
Key Financial Inc200$2.33K0.00%
Aster Capital Management (DIFC) Ltd153$1.78K0.00%
The PNC Financial Services Group, Inc.36$4190.00%
Strategic Wealth Partners, Ltd.20$2330.00%
EverSource Wealth Advisors, LLC9$1050.00%
Essential Partners LLC4$470.00%

Sold out (33)

Institutions that held ARS Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (2)

Institutions that held ARS Pharmaceuticals, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SPRY in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Wolverine Trading, LLC24,266$235.9K
Amica Retiree Medical Trust346$3.00K